Bio Protech Inc. (XKON:199290)
South Korea · Delayed Price · Currency is KRW 395.00
0.00 (0.00%)
At close: Aug 31, 2026
Bio Protech Market Cap
Bio Protech has a market cap or net worth of 4.8 billion as of September 4, 2026. Its market cap has decreased by -29.36% in one year.
Market Cap
4.80B
Enterprise Value
n/a
Revenue
20.58B
Ranking
n/a
PE Ratio
1.67
Stock Price
395.00
ChartMarket Cap Chart
Since April 5, 2017, Bio Protech's market cap has decreased from 7.43B to 4.80B, a decrease of -35.35%. That is a compound annual growth rate of -4.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 5.71B | -20.84% |
| Dec 29, 2025 | 7.22B | -16.83% |
| Dec 27, 2024 | 8.68B | -34.07% |
| Dec 28, 2023 | 13.16B | -15.35% |
| Dec 28, 2022 | 15.55B | 315.38% |
| Dec 30, 2021 | 3.74B | -54.00% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RecensMedical | 113.08B |
| Corentec | 53.56B |
| DENTIS CO.,Ltd | 40.55B |
| Finemedix | 35.30B |
| Sanigen Co. | 28.15B |
| Genolution | 24.99B |
| TASCOM | 23.42B |
| Alpha AI | 10.45B |